early intervention

R&D

Research has demonstrated that some individuals at elevated risk of Alzheimer's disease can be identified before symptoms emerge.

News

At its second attempt, Gilead has won FDA approval for chronic hepatitis D virus drug Hepcludex, four years after it was cleared in the EU.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.